Role of butyric acid and its derivatives in the treatment of colorectal cancer and hemoglobinopathies (Q34067921)

30 July 2017

1 reference

title

Role of butyric acid and its derivatives in the treatment of colorectal cancer and hemoglobinopathies (English)

1 reference

30 July 2017

1 reference

1 reference

Pouillart PR

1

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

30 July 2017

1 reference

30 July 2017

volume

63

1 reference

30 July 2017

issue

20

1 reference

30 July 2017

page(s)

1739-1760

1 reference

Identification of a second human acetyl-CoA carboxylase gene

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Butyrate production from dietary fibre and protection against large bowel cancer in a rat model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Evaluation in rats of the dose-response relationship among colonic mucosal growth, colonic fermentation, and dietary fiber

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

A comparative study of the influence of differing barley brans on DMH-induced intestinal tumours in male Sprague-Dawley rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Short chain fatty acids in human large intestine, portal, hepatic and venous blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Butyrate as a differentiating agent: pharmacokinetics, analogues and current status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Sugar composition of dietary fibre and short-chain fatty acid production during in vitro fermentation by human bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Localization and regulation of the putative membrane fatty-acid transporter (FAT) in the small intestine. Comparison with fatty acid-binding proteins (FABP)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Mercaptopropionate inhibits butyrate uptake in isolated apical membrane vesicles of the rat distal colon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Evaluation of diets containing supplemental fat with different sources of carbohydrates for lactating dairy cows

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Effects of short-chain fatty acids on growth and differentiation of the human colon-cancer cell line HT29

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Effect of sodium butyrate on mammalian cells in culture: A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Butyric acid: a small fatty acid with diverse biological functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Production of analytical quantities of recombinant proteins in Chinese hamster ovary cells using sodium butyrate to elevate gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Butyrate synchronization of hepatocytes: modulation of cycling and cell cycle regulated gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Use of sodium butyrate to enhance production of retroviral vectors expressing CFTR cDNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Treatment with propionic and butyric acid enhances expression variegation and promoter methylation in plant transgenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Stimulation of tissue-type plasminogen activator gene expression by sodium butyrate and trichostatin A in human endothelial cells involves histone acetylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Acetylation of histone H4 plays a primary role in enhancing transcription factor binding to nucleosomal DNA in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Cell cycle perturbation by sodium butyrate in tumorigenic and non-tumorigenic human urothelial cell lines assessed by flow cytometric bromodeoxyuridine/DNA analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Sodium butyrate inhibits platelet-derived growth factor-induced proliferation of vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Sodium butyrate induces neuroendocrine cytodifferentiation in the insulinoma cell line RINm5F.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Recoverin in cultured human retinoblastoma cells: enhanced expression during morphological differentiation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Specialization switch in differentiating embryonic rat liver progenitor cells in response to sodium butyrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Differentiation of pancreatic carcinoma induced by retinoic acid or sodium butyrate: a morphological and molecular analysis of four cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

DMSO, sodium butyrate, and TPA induce hypophosphorylation of RB with HL-60 cell differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Stable differentiation of a human colon adenocarcinoma cell line by sodium butyrate is associated with multidrug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Expression of plasminogen activator inhibitor type 1 (PAI-1) by HT-29di human large bowel carcinoma cells is modulated as a function of epithelial differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Effect of sodium butyrate on the antiviral and anticellular action of interferon in normal and MSV-transformed cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Constitutive and cytokine induced expression of HLA molecules, secretory component, and intercellular adhesion molecule-1 is modulated by butyrate in the colonic epithelial cell line HT-29

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Butyrate differentially affects constitutive and cytokine-induced expression of HLA molecules, secretory component (SC), and ICAM-1 in a colonic epithelial cell line (HT-29, clone m3).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Butyrate enhances major histocompatibility complex class I, HLA-DR and ICAM-1 antigen expression on differentiated human intestinal epithelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

HLA expression in hepatocellular carcinoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Development of dexamethasone-inducible tyrosine aminotransferase activity in WB-F344 rat liver epithelial stemlike cells cultured in the presence of sodium butyrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Butyrate and TGF-β Downregulate Na,K-ATPase Expression in Cultured Proximal Tubule Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Retinoids stimulate type I iodothyronine 5'-deiodinase activity in human follicular thyroid carcinoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Induction of heat labile alkaline phosphatase by butyrate in differentiating endometrial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Expression and chromosomal assignment of PTPH1 gene encoding a cytosolic protein tyrosine phosphatase homologous to cytoskeletal-associated proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Effect of sodium butyrate in combination with prostaglandin E1 and inhibitors of cyclic nucleotide phosphodiesterase on human amelanotic melanoma cells in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Effect of sodium butyrate in combination with X0irradiation, chemotherapeutic and cyclic AMP stimulating agents on neuroblastoma cells in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Enhancement by stable butyrate derivatives of antitumor and antiviral actions of interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Antitumor effect of arginine butyrate in conjunction withcorynebacterium parvum and interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Effect of coordinated therapeutic assays usingC. parvum, interferon and arginine butyrate on spontaneous disease and survival of AKR mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Differentiation therapy is potentiated by chemotherapy and hyperthermia in human and canine brain tumor cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Retinoic acid inhibits sodium butyrate-induced monocytic differentiation of HL60 cells while synergistically inducing granulocytoid differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Among 17 inducers of differentiation only sodium butyrate causes a permanent down-regulation of c-myc in Burkitt's lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Structure-activity relationship of 17 structural analogues of n-butyric acid upon c-myc expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Sodium butyrate inhibits c-myc splicing and interferes with signal transduction in ovarian carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

n-Butyrate induces plasminogen activator inhibitor type 1 messenger RNA in cultured Hep G2 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

The kinetics of induction of Hox1.6 and C-jun mRNA during three different ways of inducing differentiation in teratocarcinoma F9 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Modulation of HSP70 and HSP27 gene expression by the differentiation inducer sodium butyrate in U-937 human promonocytic leukemia cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Analysis of c-fos expression in the butyrate-induced F-98 glioma cell differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Butyrate induced apoptosis in lymphoid cells preceded by transient over-expression of HSP70 mRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

The short-chain fatty acid butyrate induces apoptosis in colorectal tumour cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Apoptosis in colorectal tumour cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Butyric acid and its monosaccharide ester induce apoptosis in the HL-60 cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Selective induction of apoptosis in myeloid leukemic cell lines by monoacetone glucose-3 butyrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Bcl-2 deregulation leads to inhibition of sodium butyrate-induced apoptosis in human colorectal carcinoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Potentiation of sodium butyrate-induced apoptosis by vanadate in human promyelocytic leukemia cell line HL-60.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Expression of multidrug resistance in response to differentiation in the K562 human leukaemia cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Modulation of P-glycoprotein phosphorylation and drug transport by sodium butyrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Variable effects of sodium butyrate on the expression and function of the MDR1 (P-glycoprotein) gene in colon carcinoma cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Induction of glutathione-S-transferase-pi by short-chain fatty acids in the intestinal cell line Caco-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Two cytotoxic cell proteinase genes are differentially sensitive to sodium butyrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Butyrate-synchronized cloned T cells retain their dependence on interleukin-2 for growth induction. A model system for growth regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Immunization against a rat colon carcinoma by sodium butyrate-treated cells but not by interleukin 2-secreting cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Importance of coordinated immune stimulation in experimental antitumor treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Colonic fermentation: metabolic and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Selective inhibition of fatty acid oxidation in colonocytes by ibuprofen: a cause of colitis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Colonic mucin synthesis is increased by sodium butyrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Butyrate increases colonocyte protein synthesis in ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Transmural trophic effect of short chain fatty acid infusions on atrophic, defunctioned rat colon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Short-chain fatty acid topical treatment in distal ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Antagonistic effects of sulfide and butyrate on proliferation of colonic mucosa: a potential role for these agents in the pathogenesis of ulcerative colitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Topical treatment of refractory distal ulcerative colitis with 5-ASA and sodium butyrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Butyrate, mesalamine, and factor XIII in experimental colitis in the rat: effects on transglutaminase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Butyrate enemas in experimental colitis and protection against large bowel cancer in a rat model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Effective surgical adjuvant therapy for high-risk rectal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Heterogeneity of human colon carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Dietary risk factors for the incidence and recurrence of colorectal adenomatous polyps. A case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Calcium ameliorates the toxic effect of deoxycholic acid on colonic epithelium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Colonic production of butyrate in patients with previous colonic cancer during long-term treatment with dietary fibre (Plantago ovata seeds).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Calcium, vitamin D, dairy foods, and the occurrence of colorectal adenomas among men and women in two prospective studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Butyrate and the colonocyte. Implications for neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Growth and intestinal differentiation are independently regulated in HT29 colon cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

gamma-Aminobutyric acid and intestinal secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

In vivo crypt surface hyperproliferation is decreased by butyrate and increased by deoxycholate in normal rat colon: associated in vivo effects on c-Fos and c-Jun expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Perspectives on interleukin-2 immunotherapy for colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Developmental genetics of the human haemoglobins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Developmental regulation of human globin genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Bone marrow transplantation for severe sickle cell anaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

For debate: bone marrow transplantation for severe thalassaemia (1). The view from Pesaro (2). To be or not to be

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Levels of fetal hemoglobin necessary for treatment of sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Pain in sickle cell disease. Rates and risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Fetal hemoglobin levels in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

The Importance of the Genetic Picture and Globin Synthesis in Determining the Clinical and Haematological Features of Thalassaemia Intermedia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Stimulation of F-cell production in patients with sickle-cell anemia treated with cytarabine or hydroxyurea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Hematologic Responses of Patients with Sickle Cell Disease to Treatment with Hydroxyurea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Delay in the fetal globin switch in infants of diabetic mothers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

The proteoglycan perlecan is expressed in the erythroleukemia cell line K562 and is upregulated by sodium butyrate and phorbol ester

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

5'-flanking sequences mediate butyrate stimulation of embryonic globin gene expression in adult erythroid cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Effects of butyrate and glucocorticoids on gamma- to beta-globin gene switching in somatic cell hybrids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Control of hemoglobin synthesis in erythroid differentiating K562 cells. I. Role of iron in erythroid cell heme synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Extended therapy with intravenous arginine butyrate in patients with beta-hemoglobinopathies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Effect of polar organic compounds on leukemic cells. Butyrate-induced partial remission of acute myelogenous leukemia in a child.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Clinical pharmacology of sodium butyrate in patients with acute leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Butyric monosaccharide ester-induced cell differentiation and anti-tumor activity in mice. Importance of their prolonged biological effect for clinical applications in cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Pharmacokinetic study of butyric acid administered in vivo as sodium and arginine butyrate salts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

A rapid, simple and sensitive gas chromatographic micromethod for the quantitation of butyric acid and other short-chain fatty acids in serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Pharmacokinetic studies of N-butyric acid mono- and polyesters derived from monosaccharides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Isobutyramide, an orally bioavailable butyrate analogue, stimulates fetal globin gene expression in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Antibody-mediated targeting of differentiation inducers to tumor cells: inhibition of colonic cancer cell growth in vitro and in vivo. A preliminary note

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Differential elimination of synthetic butyric triglycerides in vivo: a pharmacokinetic study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Derivatives of butyric acid as potential anti-neoplastic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Novel anticancer prodrugs of butyric acid. 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Comparison between the effect of butyric acid and its prodrug pivaloyloxymethylbutyrate on histones hyperacetylation in an HL-60 leukemic cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Rapid alteration of c-myc and c-jun expression in leukemic cells induced to differentiate by a butyric acid prodrug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Butyric acid and pivaloyloxymethyl butyrate, AN-9, a novel butyric acid derivative, induce apoptosis in HL-60 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Anti-tumor protection induced in mice by fatty acid conjugates: alkyl butyrates and poly(ethylene glycol) dibutyrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Fucose and galactose receptor and liver recognition by lymphoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

New stable butyrate derivatives alter proliferation and differentiation in human mammary cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Immunopharmacological activities and clinical development of muramyl peptides with particular emphasis on murabutide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Synergistic effects between recombinant interleukin-2 and the synthetic immunomodulator murabutide: selective enhancement of cytokine release and potentiation of antitumor activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Enhancement in vivo of the antiinflammatory and antitumor activities of type I interferon by association with the synthetic immunomodulator murabutide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

Enhancement by muramyl peptides of the protective response of interferon-alpha/beta against encephalomyocarditis virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

An interleukin 2/sodium butyrate combination as immunotherapy for rat colon cancer peritoneal carcinomatosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900279-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0024-3205(98)00279-3

1 reference

30 July 2017

1 reference